Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Journal of Clinical and Experimental Hepatology|April 9, 2026
Self-Reported Cognitive Function in Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Post-hoc Analysis of the MAESTRO Resmetirom TrialsZobair M Younossi, Fatema Nader, Dominic Labriola, et al.Hepatology Communications|February 27, 2026
Improvement in health-related quality of life after treatment with resmetirom in patients with the spectrum of MASLD: From early MASH to MASH cirrhosisZobair M Younossi, Fatema Nader, Dominic Labriola, et al.Gastro Hep Advances|July 22, 2025
Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Form SF-6D, and EuroQol EQ-5D InstrumentsZobair M Younossi, Maria Stepanova, Yestle Kim, et al.Hepatology (Baltimore, Md.)|September 9, 2024
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosisZobair M Younossi, Maria Stepanova, Andrei Racila, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 10, 2026
Pharmacokinetics, mass balance and metabolic profiling of resmetirom in healthy subjects and nonclinical metabolism and dispositionJames K Hennan, Raul C Camacho, Eric Solon, et al.Hepatology Communications|April 16, 2021
Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASHStephen A Harrison, Mustafa Bashir, Sam E Moussa, et al.Alimentary Pharmacology & Therapeutics|October 23, 2025
Effects of Resmetirom on Metabolic-Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon-Like Peptide-1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO-NASH TrialMazen Noureddin, Mary Rinella, Rebecca Taub, et al.Clinical and Vaccine Immunology : CVI|January 11, 2008
Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvantLin Lin, Ashraf S Ibrahim, Valentina Avanesian, et al.Journal of Pain and Symptom Management|May 18, 2010
Iyengar yoga for young adults with rheumatoid arthritis: results from a mixed-methods pilot studySubhadra Evans, Mona Moieni, Rebecca Taub, et al.Diabetes|December 29, 2005
The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapyFranz M Matschinsky, Mark A Magnuson, Dorothy Zelent, et al.Pageof 5